Mintek LV-T Pacemaker User Manual


 
24 Stratos LV/LV-T Technical Manual
Table 1: Patient Demographics at Enrollment
Characteristic Group1 Group 2 Group 3
P-value
Other Medical
History
Diabetes
Chronic Lung
Disease
Thyroid Disease
Chronic Kidney
Disease
Prior Ischemic
Stroke or TIA
Prior Embolic
Events
(non-
cerebrovascular)
N=29
13 (44.8%)
7 (24.1%)
12 (41.4%)
4 (13.8%)
7 (24.1%)
1 (2.3%)
N=36
9 (25.0%)
16 (44.4%)
12 (33.3%)
5 (13.9%)
10 (27.8%)
3 (6.0%)
N=17
4 (23.5%)
7 (41.2%)
5 (29.4%)
1 (5.9%)
6 (35.3%)
2 (8.0%)
0.287**
0.211**
0.791**
0.836**
0.726**
0.653**
*One-way ANOVA, ** Chi-Square test (2-sided)
Table 2 provides a summary of the AF medical history. Table 3
provides a summary of cardiac medications patients were taking
at the time of enrollment. Please note some categories may
equal more than 100% as several categories allow more than
one response. In some cases, complete demographic data was
not provided for all patients. There were no statistical
differences in AF medical history and cardiac medication at
enrollment between the 3 groups.